Home > Research > Publications & Outputs > Mendelian randomization of blood lipids for cor...

Associated organisational unit

View graph of relations

Mendelian randomization of blood lipids for coronary heart disease

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Mendelian randomization of blood lipids for coronary heart disease. / Holmes, Michael V.; Asselbergs, Folkert W.; Palmer, Tom M. et al.
In: European Heart Journal, Vol. 36, No. 9, 01.03.2015, p. 539-550.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Holmes, MV, Asselbergs, FW, Palmer, TM, Drenos, F, Lanktree, MB, Nelson, CP, Dale, CE, Padmanabhan, S, Finan, C, Swerdlow, DI, Tragante, V, van Iperen, EPA, Sivapalaratnam, S, Shah, S, Elbers, CC, Shah, T, Engmann, J, Giambartolomei, C, White, J, Zabaneh, D, Sofat, R, McLachlan, S, Doevendans, PA, Balmforth, AJ, Hall, AS, North, KE, Almoguera, B, Hoogeveen, RC, Cushman, M, Fornage, M, Patel, SR, Redline, S, Siscovick, DS, Tsai, MY, Karczewski, KJ, Hofker, MH, Verschuren, WM, Bots, ML, van der Schouw, YT, Melander, O, Dominiczak, AF, Morris, R, Ben-Shlomo, Y, Price, J, Kumari, M, Baumert, J, Peters, A, Thorand, B, Koenig, W, Gaunt, TR & UCLEB Consortium 2015, 'Mendelian randomization of blood lipids for coronary heart disease', European Heart Journal, vol. 36, no. 9, pp. 539-550. https://doi.org/10.1093/eurheartj/eht571

APA

Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., Tragante, V., van Iperen, E. P. A., Sivapalaratnam, S., Shah, S., Elbers, C. C., Shah, T., Engmann, J., Giambartolomei, C., White, J., ... UCLEB Consortium (2015). Mendelian randomization of blood lipids for coronary heart disease. European Heart Journal, 36(9), 539-550. https://doi.org/10.1093/eurheartj/eht571

Vancouver

Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP et al. Mendelian randomization of blood lipids for coronary heart disease. European Heart Journal. 2015 Mar 1;36(9):539-550. Epub 2014 Jan 28. doi: 10.1093/eurheartj/eht571

Author

Holmes, Michael V. ; Asselbergs, Folkert W. ; Palmer, Tom M. et al. / Mendelian randomization of blood lipids for coronary heart disease. In: European Heart Journal. 2015 ; Vol. 36, No. 9. pp. 539-550.

Bibtex

@article{1ac01fb1eae5433b8607a2baaa4e055d,
title = "Mendelian randomization of blood lipids for coronary heart disease",
abstract = "AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization.METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75).CONCLUSION: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.",
keywords = "Lipids, Heart disease, Mendelian randomization, Aetiology, Epidemiology",
author = "Holmes, {Michael V.} and Asselbergs, {Folkert W.} and Palmer, {Tom M.} and Fotios Drenos and Lanktree, {Matthew B.} and Nelson, {Christopher P.} and Dale, {Caroline E.} and Sandosh Padmanabhan and Chris Finan and Swerdlow, {Daniel I.} and Vinicius Tragante and {van Iperen}, {Erik P. A.} and Suthesh Sivapalaratnam and Sonia Shah and Elbers, {Clara C.} and Tina Shah and Jorgen Engmann and Claudia Giambartolomei and Jon White and Delilah Zabaneh and Reecha Sofat and Stela McLachlan and Doevendans, {Pieter A.} and Balmforth, {Anthony J.} and Hall, {Alistair S.} and North, {Kari E.} and Berta Almoguera and Hoogeveen, {Ron C.} and Mary Cushman and Myriam Fornage and Patel, {Sanjay R.} and Susan Redline and Siscovick, {David S.} and Tsai, {Michael Y.} and Karczewski, {Konrad J.} and Hofker, {Marten H.} and Verschuren, {W. Monique} and Bots, {Michiel L.} and {van der Schouw}, {Yvonne T.} and Olle Melander and Dominiczak, {Anna F.} and Richard Morris and Yoav Ben-Shlomo and Jackie Price and Meena Kumari and Jens Baumert and Annette Peters and Barbara Thorand and Wolfgang Koenig and Gaunt, {Tom R.} and {UCLEB Consortium}",
note = " {\textcopyright} The Author 2014. Published by Oxford University Press on behalf of the European Society of Cardiology.",
year = "2015",
month = mar,
day = "1",
doi = "10.1093/eurheartj/eht571",
language = "English",
volume = "36",
pages = "539--550",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Mendelian randomization of blood lipids for coronary heart disease

AU - Holmes, Michael V.

AU - Asselbergs, Folkert W.

AU - Palmer, Tom M.

AU - Drenos, Fotios

AU - Lanktree, Matthew B.

AU - Nelson, Christopher P.

AU - Dale, Caroline E.

AU - Padmanabhan, Sandosh

AU - Finan, Chris

AU - Swerdlow, Daniel I.

AU - Tragante, Vinicius

AU - van Iperen, Erik P. A.

AU - Sivapalaratnam, Suthesh

AU - Shah, Sonia

AU - Elbers, Clara C.

AU - Shah, Tina

AU - Engmann, Jorgen

AU - Giambartolomei, Claudia

AU - White, Jon

AU - Zabaneh, Delilah

AU - Sofat, Reecha

AU - McLachlan, Stela

AU - Doevendans, Pieter A.

AU - Balmforth, Anthony J.

AU - Hall, Alistair S.

AU - North, Kari E.

AU - Almoguera, Berta

AU - Hoogeveen, Ron C.

AU - Cushman, Mary

AU - Fornage, Myriam

AU - Patel, Sanjay R.

AU - Redline, Susan

AU - Siscovick, David S.

AU - Tsai, Michael Y.

AU - Karczewski, Konrad J.

AU - Hofker, Marten H.

AU - Verschuren, W. Monique

AU - Bots, Michiel L.

AU - van der Schouw, Yvonne T.

AU - Melander, Olle

AU - Dominiczak, Anna F.

AU - Morris, Richard

AU - Ben-Shlomo, Yoav

AU - Price, Jackie

AU - Kumari, Meena

AU - Baumert, Jens

AU - Peters, Annette

AU - Thorand, Barbara

AU - Koenig, Wolfgang

AU - Gaunt, Tom R.

AU - UCLEB Consortium

N1 - © The Author 2014. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization.METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75).CONCLUSION: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.

AB - AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization.METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75).CONCLUSION: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.

KW - Lipids

KW - Heart disease

KW - Mendelian randomization

KW - Aetiology

KW - Epidemiology

U2 - 10.1093/eurheartj/eht571

DO - 10.1093/eurheartj/eht571

M3 - Journal article

C2 - 24474739

VL - 36

SP - 539

EP - 550

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 9

ER -